Targeting the AMP-activated protein kinase for cancer prevention and therapy

Frontiers in Oncology

Volumn 3 JUL, Issue , 2013, Pages

  Kim, InYoung ^a   He, Yu Ying ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

AMPK; Apoptosis; Cancer prevention; DNA repair; Phytochemicals; Proliferation

Indexed keywords

ANTHOCYANIN; APIGENIN; BAICALEIN; BERBERINE; CAPSAICIN; CATECHIN; CELASTROL; CHRYSIN; CURCUMIN; DEGUELIN; EPIGALLOCATECHIN GALLATE; FISETIN; GENISTEIN; HISPIDULIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LUTEOLIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL KINASE; PROTEIN KINASE LKB1; QUERCETIN; RESVERATROL; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER PREVENTION; CANCER THERAPY; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; HUMAN; IONIZING RADIATION; LUNG CANCER; OVERALL SURVIVAL; PERSIMMON; PROTEIN PHOSPHORYLATION; QUALITY OF LIFE; REVIEW; SKIN CANCER;

EID: 84887020540     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00175     Document Type: Review

References (110)

1. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst (1981) 66:1191-308.
2. Surh YJ. Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer (2003) 3:768-80. doi:10.1038/nrc1189
3. Manson MM. Cancer prevention-the potential for diet to modulate molecular signalling. Trends Mol Med (2003) 9:11-8. doi:10.1016/S1471-4914(02)00002-3
4. Agarwal R. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol (2000) 60:1051-9. doi:10.1016/S0006-2952(00)00385-3
5. Ashendel CL. Diet, signal transduction and carcinogenesis. J Nutr (1995) 125:686S-91.
6. Gescher A, Pastorino U, Plummer SM, Manson MM. Suppression of tumour development by substances derived from the diet-mechanisms and clinical implications. Br J Clin Pharmacol (1998) 45:1-12. doi:10.1046/j.1365-2125.1998.00640.x
7. Kong AN, Yu R, Hebbar V, Chen C, Owuor E, Hu R, et al. Signal transduction events elicited by cancer prevention compounds. Mutat Res (2001) 48(0-481):231-41.
8. Manson MM, Gescher A, Hudson EA, Plummer SM, Squires MS, Prigent SA. Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicol Lett (2000) 11(2-113):499-505. doi:10.1016/S0378-4274(99)00211-8
9. Hardie DG. Adenosine monophosphate-activated protein kinase: a central regulator of metabolism with roles in diabetes, cancer, and viral infection. Cold Spring Harb Symp Quant Biol (2011) 76:155-64. doi:10.1101/sqb.2011.76.010819
10. Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol (2012) 13:251-62. doi:10.1038/nrm3311
11. Steinberg GR, Kemp BE. AMPK in health and disease. Physiol Rev (2009) 89:1025-78. doi:10.1152/physrev.00011.2008
12. Hardie DG. AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol (2007) 8:774-85. doi:10.1038/nrm2249
13. Hoppe S, Bierhoff H, Cado I, Weber A, Tiebe M, Grummt I, et al. AMP-activated protein kinase adapts rRNA synthesis to cellular energy supply. Proc Natl Acad Sci U S A (2009) 106:17781-6. doi:10.1073/pnas.0909873106
14. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP, et al. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol (2003) 2:28. doi:10.1186/1475-4924-2-28
15. Woods A, Johnstone SR, Dickerson K, Leiper FC, Fryer LG, Neumann D, et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol (2003) 13:2004-8. doi:10.1016/j.cub.2003.10.031
16. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature (1998) 391:184-7. doi:10.1038/34432
17. Sanchez-Cespedes M, Parrella P, Esteller M, Nomoto S, Trink B, Engles JM, et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res (2002) 62:3659-62.
18. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab (2005) 2:9-19. doi:10.1016/j.cmet.2005.05.009
19. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem (2005) 280:29060-6. doi:10.1074/jbc.M503824200
20. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, et al. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab (2005) 2:21-33. doi:10.1016/j.cmet.2005.06.005
21. Memmott RM, Gills JJ, Hollingshead M, Powers MC, Chen Z, Kemp B, et al. Phosphatidylinositol ether lipid analogues induce AMP-activated protein kinase-dependent death in LKB1-mutant non small cell lung cancer cells. Cancer Res (2008) 68:580-8. doi:10.1158/0008-5472.CAN-07-3091
22. Dykens JA, Jamieson J, Marroquin L, Nadanaciva S, Billis PA, Will Y. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. Toxicol Appl Pharmacol (2008) 233:203-10. doi:10.1016/j.taap.2008.08.013
23. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science (2005) 310:1642-6. doi:10.1126/science.1120781
24. Ben Sahra I, Laurent K, Giuliano S, Larbret F, Ponzio G, Gounon P, et al. Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells. Cancer Res (2010) 70:2465-75. doi:10.1158/0008-5472.CAN-09-2782
25. El-Mir MY, Nogueira V, Fontaine E, Averet N, Rigoulet M, Leverve X. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J Biol Chem (2000) 275:223-8. doi:10.1074/jbc.275.1.223
26. Evans JM, Donnelly LA, Emslie-Smith AM, Alessi DR, Morris AD. Metformin and reduced risk of cancer in diabetic patients. BMJ (2005) 330:1304-5. doi:10.1136/bmj.38415.708634.F7
27. Jiralerspong S, Palla SL, Giordano SH, Meric-Bernstam F, Liedtke C, Barnett CM, et al. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol (2009) 27:3297-302. doi:10.1200/JCO.2009.19.6410
28. Huang X, Wullschleger S, Shpiro N, McGuire VA, Sakamoto K, Woods YL, et al. Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice. Biochem J (2008) 412:211-21. doi:10.1042/BJ20080557
29. Sanli T, Rashid A, Liu C, Harding S, Bristow RG, Cutz JC, et al. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys (2010) 78:221-9. doi:10.1016/j.ijrobp.2010.03.005
30. Giordanetto F, Karis D. Direct AMP-activated protein kinase activators: a review of evidence from the patent literature. Expert Opin Ther Pat (2012) 22:1467-77. doi:10.1517/13543776.2012.743994
31. Yun H, Ha J. AMP-activated protein kinase modulators: a patent review (2006-2010). Expert Opin Ther Pat (2011) 21:983-1005. doi:10.1517/13543776.2011.577069
32. Dazert E, Hall MN. mTOR signaling in disease. Curr Opin Cell Biol (2011) 23:744-55. doi:10.1016/j.ceb.2011.09.003
33. Manning BD, Cantley LC. Rheb fills a GAP between TSC and TOR. Trends Biochem Sci (2003) 28:573-6. doi:10.1016/j.tibs.2003.09.003
34. Imamura K, Ogura T, Kishimoto A, Kaminishi M, Esumi H. Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem Biophys Res Commun (2001) 287:562-7. doi:10.1006/bbrc.2001.5627
35. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, et al. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell (2005) 18:283-93. doi:10.1016/j.molcel.2005.03.027
36. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, et al. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol (2007) 9:218-24. doi:10.1038/ncb1537
37. Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol (2011) 13:1016-23. doi:10.1038/ncb2329
38. Puissant A, Auberger P. AMPK-and p62/SQSTM1-dependent autophagy mediate Resveratrol-induced cell death in chronic myelogenous leukemia. Autophagy (2010) 6:655-7. doi:10.4161/auto.6.5.12126
39. Puissant A, Robert G, Auberger P. Targeting autophagy to fight hematopoietic malignancies. Cell Cycle (2010) 9:3470-8. doi:10.4161/cc.9.17.13048
40. Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature (2008) 451:1069-75. doi:10.1038/nature06639
41. Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Ohsumi Y. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol (2000) 150:1507-13. doi:10.1083/jcb.150.6.1507
42. Lala PK, Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol (2001) 2:149-56. doi:10.1016/S1470-2045(00)00256-4
43. Wu CL, Qiang L, Han W, Ming M, Viollet B, He YY. Role of AMPK in UVB-induced DNA damage repair and growth control. Oncogene (2013) 32:2682-9. doi:10.1038/onc.2012.279
44. Liu H, Scholz C, Zang C, Schefe JH, Habbel P, Regierer AC, et al. Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro. Anticancer Res (2012) 32:1627-37.
45. Lee KH, Hsu EC, Guh JH, Yang HC, Wang D, Kulp SK, et al. Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator. J Biol Chem (2011) 286:39247-58. doi:10.1074/jbc.M111.264598
46. Appleyard MV, Murray KE, Coates PJ, Wullschleger S, Bray SE, Kernohan NM, et al. Phenformin as prophylaxis and therapy in breast cancer xenografts. Br J Cancer (2012) 106:1117-22. doi:10.1038/bjc.2012.56
47. El-Masry OS, Brown BL, Dobson PR. Effects of activation of AMPK on human breast cancer cell lines with different genetic backgrounds. Oncol Lett (2012) 3:224-8.
48. Nanjundan M, Byers LA, Carey MS, Siwak DR, Raso MG, Diao L, et al. Proteomic profiling identifies pathways dysregulated in non-small cell lung cancer and an inverse association of AMPK and adhesion pathways with recurrence. J Thorac Oncol (2010) 5:1894-904. doi:10.1097/JTO.0b013e3181f2a266
49. William WN, Kim JS, Liu DD, Solis L, Behrens C, Lee JJ, et al. The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival. Ann Oncol (2012) 23:78-85. doi:10.1093/annonc/mdr036
50. Dong LX, Sun LL, Zhang X, Pan L, Lian LJ, Chen Z, et al. Negative regulation of mTOR activity by LKB1-AMPK signaling in non-small cell lung cancer cells. Acta Pharmacol Sin (2013) 34:314-8. doi:10.1038/aps.2012.143
51. Wu N, Gu C, Gu H, Hu H, Han Y, Li Q. Metformin induces apoptosis of lung cancer cells through activating JNK/p38 MAPK pathway and GADD153. Neoplasma (2011) 58:482-90. doi:10.4149/neo_2011_06_482
52. Memmott RM, Mercado JR, Maier CR, Kawabata S, Fox SD, Dennis PA. Metformin prevents tobacco carcinogen-induced lung tumorigenesis. Cancer Prev Res (Phila) (2010) 3:1066-76. doi:10.1158/1940-6207.CAPR-10-0055
53. Kuznetsov JN, Leclerc GJ, Leclerc GM, Barredo JC. AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia. Mol Cancer Ther (2011) 10:437-47. doi:10.1158/1535-7163.MCT-10-0777
54. Leclerc GM, Leclerc GJ, Fu G, Barredo JC. AMPK-induced activation of Akt by AICAR is mediated by IGF-1R dependent and independent mechanisms in acute lymphoblastic leukemia. J Mol Signal (2010) 5:15. doi:10.1186/1750-2187-5-15
55. Sengupta TK, Leclerc GM, Hsieh-Kinser TT, Leclerc GJ, Singh I, Barredo JC. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy. Mol Cancer (2007) 6:46. doi:10.1186/1476-4598-6-46
56. Campas C, Lopez JM, Santidrian AF, Barragan M, Bellosillo B, Colomer D, et al. Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes. Blood (2003) 101:3674-80. doi:10.1182/blood-2002-07-2339
57. Drakos E, Atsaves V, Li J, Leventaki V, Andreeff M, Medeiros LJ, et al. Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma. Leukemia (2009) 23:784-90. doi:10.1038/leu.2008.348
58. Vakana E, Altman JK, Glaser H, Donato NJ, Platanias LC. Antileukemic effects of AMPK activators on BCR-ABL-expressing cells. Blood (2011) 118:6399-402. doi:10.1182/blood-2011-01-332783
59. Green AS, Chapuis N, Maciel TT, Willems L, Lambert M, Arnoult C, et al. The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation. Blood (2010) 116:4262-73. doi:10.1182/blood-2010-02-269837
60. Petti C, Vegetti C, Molla A, Bersani I, Cleris L, Mustard KJ, et al. AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway. Melanoma Res (2012) 22:341-50. doi:10.1097/CMR.0b013e3283544929
61. Martin MJ, Hayward R, Viros A, Marais R. Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A. Cancer Discov (2012) 2:344-55. doi:10.1158/2159-8290.CD-11-0280
62. Byekova YA, Herrmann JL, Xu J, Elmets CA, Athar M. Liver kinase B1 (LKB1) in the pathogenesis of UVB-induced murine basal cell carcinoma. Arch Biochem Biophys (2011) 508:204-11. doi:10.1016/j.abb.2011.01.006
63. Zhang J, Bowden GT. UVB irradiation regulates Cox-2 mRNA stability through AMPK and HuR in human keratinocytes. Mol Carcinog (2008) 47:974-83. doi:10.1002/mc.20450
64. Beevers CS, Chen L, Liu L, Luo Y, Webster NJ, Huang S. Curcumin disrupts the Mammalian target of rapamycin-raptor complex. Cancer Res (2009) 69:1000-8. doi:10.1158/0008-5472.CAN-08-2367
65. Lee YK, Lee WS, Hwang JT, Kwon DY, Surh YJ, Park OJ. Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells. J Agric Food Chem (2009) 57:305-10. doi:10.1021/jf802737z
66. Lee YK, Park SY, Kim YM, Park OJ. Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Ann N Y Acad Sci (2009) 1171:489-94. doi:10.1111/j.1749-6632.2009.04699.x
67. Pan W, Yang H, Cao C, Song X, Wallin B, Kivlin R, et al. AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells. Oncol Rep (2008) 20:1553-9.
68. Biasutto L, Mattarei A, Zoratti M. Resveratrol and health: the starting point. Chembiochem (2012) 13:1256-9. doi:10.1002/cbic.201200193
69. Constant J. Alcohol, ischemic heart disease, and the French paradox. Clin Cardiol (1997) 20:420-4. doi:10.1002/clc.4960200504
70. Fremont L. Biological effects of resveratrol. Life Sci (2000) 66:663-73. doi:10.1016/S0024-3205(99)00410-5
71. Tome-Carneiro J, Larrosa M, Gonzalez-Sarrias A, Tomas-Barberan FA, Garcia-Conesa MT, Espin JC. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des (2013). [Epub ahead of print].
72. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science (1997) 275:218-20. doi:10.1126/science.275.5297.218
73. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov (2006) 5:493-506. doi:10.1038/nrd2060
74. Hwang JT, Kwak DW, Lin SK, Kim HM, Kim YM, Park OJ. Resveratrol induces apoptosis in chemoresistant cancer cells via modulation of AMPK signaling pathway. Ann N Y Acad Sci (2007) 1095:441-8. doi:10.1196/annals.1397.047
75. Yi CO, Jeon BT, Shin HJ, Jeong EA, Chang KC, Lee JE, et al. Resveratrol activates AMPK and suppresses LPS-induced NF-kappaB-dependent COX-2 activation in RAW 264.7 macrophage cells. Anat Cell Biol (2011) 44:194-203. doi:10.5115/acb.2011.44.3.194
76. Puissant A, Robert G, Fenouille N, Luciano F, Cassuto JP, Raynaud S, et al. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res (2010) 70:1042-52. doi:10.1158/0008-5472.CAN-09-3537
77. Castillo-Pichardo L, Dharmawardhane SF. Grape polyphenols inhibit Akt/mammalian target of rapamycin signaling and potentiate the effects of gefitinib in breast cancer. Nutr Cancer (2012) 64:1058-69. doi:10.1080/01635581.2012.716898
78. Rashid A, Liu C, Sanli T, Tsiani E, Singh G, Bristow RG, et al. Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK Akt and mTOR pathways. Radiat Oncol (2011) 6:144. doi:10.1186/1748-717X-6-144
79. Yuan Y, Xue X, Guo RB, Sun XL, Hu G. Resveratrol enhances the antitumor effects of temozolomide in glioblastoma via ROS-dependent AMPK-TSC-mTOR signaling pathway. CNS Neurosci Ther (2012) 18:536-46. doi:10.1111/j.1755-5949.2012.00319.x
80. Zhang L, Jing H, Cui L, Li H, Zhou B, Zhou G, et al. 3,4-Dimethoxystilbene, a resveratrol derivative with anti-angiogenic effect, induces both macroautophagy and apoptosis in endothelial cells. J Cell Biochem (2013) 114:697-707. doi:10.1002/jcb.24411
81. Kandaswami C, Lee LT, Lee PP, Hwang JJ, Ke FC, Huang YT, et al. The antitumor activities of flavonoids. In vivo (2005) 19:895-909.
82. Park CE, Yun H, Lee EB, Min BI, Bae H, Choe W, et al. The antioxidant effects of genistein are associated with AMP-activated protein kinase activation and PTEN induction in prostate cancer cells. J Med Food (2010) 13:815-20. doi:10.1089/jmf.2009.1359
83. Sanchez Y, Amran D, Fernandez C, de Blas E, Aller P. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK). Int J Cancer (2008) 123:1205-14. doi:10.1002/ijc.23639
84. Lee YK, Park OJ. Regulation of mutual inhibitory activities between AMPK and Akt with quercetin in MCF-7 breast cancer cells. Oncol Rep (2010) 24:1493-7.
85. Jang KY, Jeong SJ, Kim SH, Jung JH, Kim JH, Koh W, et al. Activation of reactive oxygen species/AMP activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma U266 cells. Cancer Lett (2012) 319:197-202. doi:10.1016/j.canlet.2012.01.008
86. Khan N, Afaq F, Khusro FH, Mustafa Adhami V, Suh Y, Mukhtar H. Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin. Int J Cancer (2012) 130:1695-705. doi:10.1002/ijc.26178
87. Suh Y, Afaq F, Khan N, Johnson JJ, Khusro FH, Mukhtar H. Fisetin induces autophagic cell death through suppression of mTOR signaling pathway in prostate cancer cells. Carcinogenesis (2010) 31:1424-33. doi:10.1093/carcin/bgq115
88. Kim HJ, Kim SK, Kim BS, Lee SH, Park YS, Park BK, et al. Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. J Agric Food Chem (2010) 58:8643-50. doi:10.1021/jf101510z
89. Jung JH, Lee JO, Kim JH, Lee SK, You GY, Park SH, et al. Quercetin suppresses HeLa cell viability via AMPK-induced HSP70 and EGFR down-regulation. J Cell Physiol (2010) 223:408-14. doi:10.1002/jcp.22049
90. Tong X, Smith KA, Pelling JC. Apigenin, a chemopreventive bioflavonoid, induces AMP-activated protein kinase activation in human keratinocytes. Mol Carcinog (2012) 51:268-79. doi:10.1002/mc.20793
91. Hwang JT, Park OJ, Lee YK, Sung MJ, Hur HJ, Kim MS, et al. Anti-tumor effect of luteolin is accompanied by AMP-activated protein kinase and nuclear factor-kappaB modulation in HepG2 hepatocarcinoma cells. Int J Mol Med (2011) 28:25-31. doi:10.3892/ijmm.2011.667
92. Gills JJ, Kosmeder J 2nd, Moon RC, Lantvit DD, Pezzuto JM. Effect of deguelin on UVB-induced skin carcinogenesis. J Chemother (2005) 17:297-301.
93. Kim JH, Lee JO, Lee SK, Kim N, You GY, Moon JW, et al. Celastrol suppresses breast cancer MCF-7 cell viability via the AMP-activated protein kinase (AMPK)-induced p53-polo like kinase 2 (PLK-2) pathway. Cell Signal (2013) 25:805-13. doi:10.1016/j.cellsig.2012.12.005
94. Shao JJ, Zhang AP, Qin W, Zheng L, Zhu YF, Chen X. AMP-activated protein kinase (AMPK) activation is involved in chrysin-induced growth inhibition and apoptosis in cultured A549 lung cancer cells. Biochem Biophys Res Commun (2012) 423:448-53. doi:10.1016/j.bbrc.2012.05.123
95. Hwang JT, Ha J, Park IJ, Lee SK, Baik HW, Kim YM, et al. Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett (2007) 247:115-21. doi:10.1016/j.canlet.2006.03.030
96. Chen D, Pamu S, Cui Q, Chan TH, Dou QP. Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells. Bioorg Med Chem (2012) 20:3031-7. doi:10.1016/j.bmc.2012.03.002
97. Shimizu M, Sakai H, Shirakami Y, Yasuda Y, Kubota M, Terakura D, et al. Preventive effects of (-)-epigallocatechin gallate on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db Mice. Cancer Prev Res (Phila) (2011) 4:396-403. doi:10.1158/1940-6207.CAPR-10-0331
98. Yang XW, Wang XL, Cao LQ, Jiang XF, Peng HP, Lin SM, et al. Green tea polyphenol epigallocatechin-3-gallate enhances 5-fluorouracil-induced cell growth inhibition of hepatocellular carcinoma cells. Hepatol Res (2012) 42:494-501. doi:10.1111/j.1872-034X.2011.00947.x
99. Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS, Lim JS. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem Pharmacol (2012) 83:385-94. doi:10.1016/j.bcp.2011.11.008
100. Park JJ, Seo SM, Kim EJ, Lee YJ, Ko YG, Ha J, et al. Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin beta1 signaling. Biochem Biophys Res Commun (2012) 426:461-7. doi:10.1016/j.bbrc.2012.08.091
101. Khanal P, Oh WK, Thuong PT, Cho SD, Choi HS 24-Hydroxyursolic acid from the leaves of the Diospyros kaki (Persimmon) induces apoptosis by activation of AMP-activated protein kinase. Planta Med (2010) 76:689-93. doi:10.1055/s-0029-1240678
102. Khanal P, Oh WK, Yun HJ, Namgoong GM, Ahn SG, Kwon SM, et al. p-HPEA-EDA, a phenolic compound of virgin olive oil, activates AMP-activated protein kinase to inhibit carcinogenesis. Carcinogenesis (2011) 32:545-53. doi:10.1093/carcin/bgr001
103. Kim YM, Hwang JT, Kwak DW, Lee YK, Park OJ. Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells. Ann N Y Acad Sci (2007) 1095:496-503. doi:10.1196/annals.1397.053
104. Harada S, Kishimoto M, Kobayashi M, Nakamoto K, Fujita-Hamabe W, Chen HH, et al. Honokiol suppresses the development of post-ischemic glucose intolerance and neuronal damage in mice. J Nat Med (2012) 66:591-9. doi:10.1007/s11418-011-0623-x
105. Lin JN, Lin VC, Rau KM, Shieh PC, Kuo DH, Shieh JC, et al. Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation. J Agric Food Chem (2010) 58:1584-92. doi:10.1021/jf9035782
106. Lee YK, Lee WS, Kim GS, Park OJ. Anthocyanins are novel AMPKalpha1 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation. Oncol Rep (2010) 24:1471-7.
107. Ding D, Zhang B, Meng T, Ma Y, Wang X, Peng H, et al. Novel synthetic baicalein derivatives caused apoptosis and activated AMP-activated protein kinase in human tumor cells. Org Biomol Chem (2011) 9:7287-91. doi:10.1039/c1ob06094e
108. Lin YC, Hung CM, Tsai JC, Lee JC, Chen YL, Wei CW, et al. Hispidulin potently inhibits human glioblastoma multiforme cells through activation of AMP-activated protein kinase (AMPK). J Agric Food Chem (2010) 58:9511-7. doi:10.1021/jf1019533
109. Choi Y, Lee JH. The combination of tephrosin with 2-deoxy-D-glucose enhances the cytotoxicity via accelerating ATP depletion and blunting autophagy in human cancer cells. Cancer Biol Ther (2011) 12:989-96. doi:10.4161/cbt.12.11.18364
110. 2. Ann N Y Acad Sci (2009) 1171:538-44. doi:10.1111/j.1749-6632.2009.04698.x